McCauley v. Purdue Pharma, L.P.

224 F. Supp. 2d 1066, 2002 U.S. Dist. LEXIS 18407, 2002 WL 31174450
CourtDistrict Court, W.D. Virginia
DecidedOctober 1, 2002
Docket2:01CV00080
StatusPublished
Cited by2 cases

This text of 224 F. Supp. 2d 1066 (McCauley v. Purdue Pharma, L.P.) is published on Counsel Stack Legal Research, covering District Court, W.D. Virginia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
McCauley v. Purdue Pharma, L.P., 224 F. Supp. 2d 1066, 2002 U.S. Dist. LEXIS 18407, 2002 WL 31174450 (W.D. Va. 2002).

Opinion

MEMORANDUM OPINION

SARGENT, United States Magistrate Judge.

These consolidated cases are before the undersigned on the Motion For Ex Parte Contact, (Docket Item No. 150) (the “Motion”), filed on behalf of the defendants. 1 Oral argument was presented by counsel on September 10, 2002. Based on the reasons set forth below, I will deny the Motion.

I. Procedural History

These consolidated cases involve claims of five plaintiffs against the manufacturers and distributors of OxyContin, a narcotic pain medication. The plaintiffs claim that they' suffered injury when they became addicted to OxyContin. By the Motion, the defendants seek the permission of the court to conduct ex parte in formal interviews with each of the plaintiffs treating physicians. To date, the defendants have identified 45 such physicians. The Revised Joint Discovery Plan entered May 20, 2002, (Docket Item No. 124), limits the defendants, as a group, to 25 depositions, excluding expert witness depositions. While plaintiffs have offered, through their counsel, to arrange for defense counsel to speak informally with each of their treating physicians, the plaintiffs will not agree to allow these interviews to be conducted by defense counsel ex parte.

II. Analysis

Because this court’s jurisdiction in these matters is based on diversity of citizenship, *1068 Virginia law governs all substantive issues. See Erie R.R. Co. v. Tompkins, 304 U.S. 64, 72-73, 58 S.Ct. 817, 82 L.Ed. 1188 (1938). Because Virginia law governs the substantive issues, Virginia law also governs the issue of privilege of a witness. See Fed.R.Evid. 501; Virmani v. Novant Health, Inc., 259 F.3d 284, 286 n. 3 (4th Cir.2001). While the common law of Virginia did not recognize a physician-patient privilege, Virginia has enacted a qualified statutory privilege limited to civil proceedings. See Pierce v. Caday, 244 Va. 285, 289, 422 S.E.2d 371, 373 (1992). Virginia Code Annotated § 8.01-399 states, in pertinent part:

Communications between physicians and patients. — A. Except at the request or with the consent of the patient, or as provided in this section, no duly licensed practitioner of any branch of the healing arts shall be required to testify in any civil action, respecting any information that he may have acquired in attending, examining or treating the patient in a professional capacity.
B. If the physical or mental condition of the patient is at issue in a civil action, the diagnosis or treatment plan of the practitioner, as documented in the patient’s medical record, during the time of the practitioner’s treatment, together with the facts communicated to, or otherwise learned by, such practitioner in connection with such attendance, examination or treatment shall be disclosed but only in discovery pursuant to the Rules of Court or through testimony at the trial of the action. In addition, disclosure may be ordered when a court, in the exercise of sound discretion, deems it necessary to the proper administration of justice.
D. Neither a lawyer nor anyone acting on the lawyer’s behalf shall obtain, in connection with pending or threatened litigation, information concerning a patient from a practitioner of any branch of the healing arts without the consent of the patient, except through discovery pursuant to the Rules of the Court as herein provided....

Va.Code Ann. § 8.01-399 (Michie 2000 & Supp.2002). It is also important to note that the Virginia Supreme Court has held that this statute not only sets out a rule of evidence, but it also provides grounds for a cause of action against any practitioner who discloses a patient’s medical records in violation of it. See Fairfax Hospital v. Curtis, 254 Va. 437, 441, 492 S.E.2d 642, 644 (1997).

The Motion appears to raise an issue of first impression in Virginia. 2 May a court in a civil proceeding in which a plaintiffs physical or mental condition is at issue order a plaintiffs treating physician to submit to an informal ex parte interview with defense counsel when the plaintiff has not requested or consented to such an interview? The defendants argue that the language of the statute explicitly allows a court to order such a disclosure. In support of their argument the defendants rely on subsection B, which states: “In addition, disclosure may be ordered when a court, in the exercise of sound discretion, deems it necessary to the proper administration of justice.” Va.Code Ann. § 8.01-399(B). The plaintiffs, on the other hand, point out that the statute, in two separate subsections, states that any such disclosure may occur only in or through “discovery pursuant to the Rules of the Court.” See Va.Code Ann. § 8.01 — 399(B), (D).

*1069 Since the physician-patient privilege in Virginia is a creation of statute, the court’s decision on the Motion turns on the construction of this statute. Furthermore, the court should examine the statute using the proper Virginia rules of Construction. In re Blackwell, 115 B.R. 86, 88 (Bkrtcy. W.D.Va.1990). If the plain meaning of a statute is unambiguous, however, the court’s interpretative task is at an end, and the statute must be applied in according to its plain meaning. See Hall v. McCoy, 89 F.Supp.2d 742, 744-45 (W.D.Va.2000); Johnson v. Garraghty, 57 F.Supp.2d 321, 325-26 (E.D.Va.1999). When a statute is plain and unambiguous, a court may look no further than the words of the statute itself to determine its meaning. See Harrison & Bates Inc. v. Featherstone Assocs., 253 Va. 364, 368, 484 S.E.2d 883, 885 (1997). Only if the operative statutory language is ambiguous, may the court refer to the statute’s legislative history, prior interpretations, related statutes and the underlying public policy considerations to ascertain its purpose. See Hall, 89 F.Supp.2d at 745.

In this case, I find that the unambiguous language of Virginia Code Annotated § 8.01-399, does not allow the informal ex parte contact with the plaintiffs’ treating physicians that is sought by the defendants. The plain language of this statute states that in a case such as this one, where a plaintiffs physical or mental conditions at issue, a physician shall disclose information relating to his examination and treatment of the plaintiff “but only in discovery pursuant to the Rules of Court or through testimony at the trial of the action.” Va.Code AnN. § 8.01-399(B).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Hatfill v. New York Times Co.
459 F. Supp. 2d 462 (E.D. Virginia, 2006)

Cite This Page — Counsel Stack

Bluebook (online)
224 F. Supp. 2d 1066, 2002 U.S. Dist. LEXIS 18407, 2002 WL 31174450, Counsel Stack Legal Research, https://law.counselstack.com/opinion/mccauley-v-purdue-pharma-lp-vawd-2002.